Clinical Trials & Research

Partnership Feature – The Retina Clinic London

The Retina Clinic London

Devon in Sight is committed to providing accurate and impartial Information, Advice and Guidance to people who are blind or partially sighted, their family, friends and carers.

Over the last few years we have built up a dynamic relationship with the world-famous Retina Clinic London.

The Retina Clinic London is dedicated to advancing retinal care, through cutting-edge research and clinical innovation. They actively collaborate with the pharmaceutical industry to bring the latest treatments to patients. Therefore, ensuring that individuals have greater choice in their ophthalmic care.

All clinical trials conducted at their clinic have full ethics committee approvals, ensuring patient safety, ethical integrity, and scientific validity. In many of these studies, Professor Paulo Stanga serves as the Chief Investigator at a national level. Overseeing the trial’s implementation across multiple sites, and playing a key role in the ethics approval process.

Their clinical trials provide patients with early access to pioneering therapies, often years before they become widely available. Led by Professor Stanga and his team of world-renowned retinal specialists, they focus on developing new diagnostic techniques, advanced treatments, and surgical innovations to improve vision outcomes.

Clinical Trials

They are currently recruiting for clinical trials in the following conditions:

  • Geographic Atrophy (GA). Dry AMD
  • Wet Age-Related Macular Degeneration (Wet AMD)
  • Vitreous Floaters & Opacities (VFO)
  • Diabetic Retinopathy & Diabetic Maculopathy
  • Gene Therapy for Inherited Retinal Diseases (including X-Linked Retinitis Pigmentosa, Usher Syndrome Type 1B, and Stargardt Disease)
The Retina Clinic London team stood outside their premises in Harley Street - London

New Clinical Trial for Stargardt's

The Retina Clinic has become the first site for a new clinical trial in Stargardt’s. This is a Phase 1 industry-sponsored gene therapy study. Stargardt disease is a rare, inherited condition causing progressive loss of central vision, affecting detailed and colour

sight due to damage in the macula (centre of the retina), often starting in childhood with blurry vision, wavy sight, or blind spots, but typically leaving peripheral vision intact, with no cure but management focused on low vision aids and supportive care. It’s linked to gene mutations (like ABCA4), causing buildup of toxic waste (lipofuscin) in the eye, leading to photoreceptor cell death.

They will be receiving patients from across the United Kingdom and looking after them at their site. All clinical trials conducted at Retina Clinic London have full ethics committee approvals, ensuring patient safety, ethical integrity, and scientific validity. In many of these studies, Professor Paulo Stanga serves as the Chief Investigator at a national level, overseeing the trial’s implementation across multiple sites and playing a key role in the ethics approval process.

As usual, the trial is free of charge with all travel expenses covered for you and an accompanying person. This means that it will be easy for you to take the train to London for the study and to be accompanied as well. You can also stay overnight in London if necessary for some of the visits, for example, for the surgery.

Supporting You on Your Research Journey

At The Retina Clinic London, they understand that taking part in a clinical trial is a meaningful decision, and they’re here to ensure that your experience is as smooth and supported as possible. All study-related costs are fully covered, including treatments, tests, and follow-up appointments.

Depending on the specific study, allowances may be available to reimburse travel and accommodation expenses, including those for a companion, if permitted.

The availability of these allowances - and the maximum amounts that can be reimbursed - are determined by each individual study. Where included, overnight stays can also be arranged for patients travelling from further afield. This is great news for people living in Devon!

Their goal is to remove unnecessary barriers to participation, so that those who wish to contribute to research - and potentially benefit from early access to innovative treatments - can do so comfortably, and with peace of mind.

If you are interested in participating in a trial, their team will guide you through the process to determine if a study is suitable for you.

Who is Professor Paulo E. Stanga?

With over 30 years’ experience in Ophthalmology, and a focus on Medical and Surgical Retina, including Macular Degeneration, Diabetic Retinopathy, Vitreous Floaters, Cataracts, Retinal Laser, R&D New Therapies, Surgical Technology, Advanced Imaging & Clinical Studies; Professor Stanga is committed to advancing the realm of eye care, and is dedicated to transforming lives through pioneering work in Ophthalmology.

In a relentless pursuit of excellence and with the aim of delivering personalised and bespoke eye care, after leaving the NHS in 2019 following 21 years’ experience, Professor Stanga founded The Retina Clinic London. This is the UK's first independent, self-contained facility, combining a fully equipped on-site operating theatre and retina clinic with dedicated academic and research activities, including participation in industry-sponsored clinical trials.

These initiatives are dedicated to pushing the boundaries of eye care, fostering innovation, developing new diagnostic and treatment techniques for the betterment of patients and very importantly, providing patient choice outside of the NHS not only in terms of clinical care but also of access to clinical trials.

His contributions extend to having set up an independent Clinical & Research Fellowship Program at The Retina Clinic London.

Prof. Stanga is Fully Registered Medical Practitioner with Specialist Registration, General Medical Council (GMC) UK.

GMC Reference No 4759748

 

Whilst Devon in Sight cannot endorse any product or service we can furnish you with more information for you and your Health Care Professional to make informed choices.